Intra-articular Glucocorticoid Treatment of the Elbow
The Importance of Immobilisation After Intra-articular Glucocorticoid Treatment for Elbow Synovitis - a Randomised and Controlled Study
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
BACKGROUND: Intra-articular glucocorticoid injections are frequently used to relieve symptoms of arthritis. Postinjection rest has been shown to improve the outcome of knee joint injections, but not for wrist injections. Consequently, different joints respond differently on postinjection regimens. OBJECTIVES: To investigate whether better treatment results might be achieved of post-injection rest following intra-articular glucocorticoid treatment for elbow synovitis. METHODS: 90 patients with rheumatoid arthritis (RA) and elbow synovitis were treated with 20 mg intra-articular triamcinolone hexacetonide and randomised to either a 48 hour immobilisation in a triangular sling (n=46) or normal activity without restrictions (n=44). Primary endpoint was relapse of synovitis. In addition, pain, function according to a self assessment questionnaire (PREE) and range of movement were followed for six months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable rheumatoid-arthritis
Started Jan 2006
Typical duration for not_applicable rheumatoid-arthritis
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 3, 2009
CompletedFirst Posted
Study publicly available on registry
September 7, 2009
CompletedResults Posted
Study results publicly available
November 11, 2009
CompletedMarch 14, 2019
October 1, 2009
2.9 years
September 3, 2009
September 10, 2009
February 18, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Relapse of Arthritis
The patients were followed for six months and if signs and symptoms recurred in between the patients were told to contact the rheumatology department. In such cases the elbow was re-examined and if a relapse could be confirmed the duration of effect was recorded and if needed the patient was offered another injection.
Regular visits at one week, 3 months and 6 months.
Study Arms (2)
Activity
NO INTERVENTIONNormal activity without restrictions
immobilisation
ACTIVE COMPARATOR48 hours postinjection rest
Interventions
Intervention group: Immobilisation 48 hours in a triangular sling (mitella) Control group: normal activity without restrictions
Eligibility Criteria
You may qualify if:
- Rheumatoid arthritis, and
- Clinical signs of elbow synovitis
You may not qualify if:
- Patients in function class 4 according to Steinbrocker as well as patients with oral glucocorticoid treatment corresponding to more than 7.5 mg prednisolone or intra-articular treatment in the joint the past three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Gävleborglead
- Meda ABcollaborator
Related Publications (1)
Weitoft T, Forsberg C. Importance of immobilization after intraarticular glucocorticoid treatment for elbow synovitis: a randomized controlled study. Arthritis Care Res (Hoboken). 2010 May;62(5):735-7. doi: 10.1002/acr.20039.
PMID: 20461791DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Tomas Weitoft
- Organization
- Department of Research and Development County Council of Gavleborg/Uppsala University
Study Officials
- PRINCIPAL INVESTIGATOR
Tomas Weitoft, MD PhD
Department of Research and Development County Council of Gävleborg/Uppsala University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2009
First Posted
September 7, 2009
Study Start
January 1, 2006
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
March 14, 2019
Results First Posted
November 11, 2009
Record last verified: 2009-10